A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Valacyclovir Caplets Under Fed Conditions.

Trial Profile

A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Valacyclovir Caplets Under Fed Conditions.

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Jun 2010

At a glance

  • Drugs Valaciclovir (Primary)
  • Indications Cytomegalovirus infections; Herpes simplex virus infections; Herpes zoster; Herpesvirus infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 09 Jun 2010 According to a Roxane Laboratories Inc media release, the US Food and Drug Administration has approved the Abbreviated New Drug Application (ANDA) of Valacyclovir Hydrochloride Tablets 500mg and 1g.
    • 01 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top